ABcann Names Former GlaxoSmithKline Executive Paul Lucas as Chairman

Visit the ABcann Global Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors.

ABcann Global Appoints New Independent Chair

NAPANEE, Ontario, Oct. 17, 2017 (GLOBE NEWSWIRE) — ABcann Global Corporation (TSX-V:ABCN) (“ABcann” or the “Company”) today announces that Ken Clement, founder and Executive Chair, has decided to step down from his position as Executive Chair, but will continue

... read more at: